D.B. Root & Company LLC Sells 187 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

D.B. Root & Company LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 837 shares of the medical equipment provider’s stock after selling 187 shares during the quarter. D.B. Root & Company LLC’s holdings in Intuitive Surgical were worth $411,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the period. Capital Research Global Investors purchased a new stake in Intuitive Surgical during the first quarter valued at about $374,390,000. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after acquiring an additional 493,126 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its stake in shares of Intuitive Surgical by 51.2% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 893,341 shares of the medical equipment provider’s stock valued at $356,524,000 after acquiring an additional 302,382 shares during the last quarter. Finally, Strategic Financial Concepts LLC raised its stake in shares of Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after acquiring an additional 265,461 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 68,246 shares of company stock worth $33,839,308 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Leerink Partners increased their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Citigroup increased their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Barclays raised their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Finally, Robert W. Baird raised their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Trading Up 0.1 %

Shares of NASDAQ:ISRG opened at $515.55 on Thursday. The company has a market cap of $183.63 billion, a PE ratio of 82.89, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39. The stock has a 50 day moving average of $492.30 and a 200 day moving average of $450.05. Intuitive Surgical, Inc. has a 12-month low of $269.49 and a 12-month high of $525.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.